BioInvent receives EMA support for BI-1808
18 november, 2025
18 november, 2025
BioInvent has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) regarding orphan drug designation for BI-1808 in cutaneous T-cell lymphoma. According to CEO Martin Welschof, this step – together with the encouraging clinical data generated to date – reinforces the company’s commitment to advancing BI-1808 as a novel immunotherapy for CTCL patients.
Read the article at biostock.se:
BioInvent receives EMA support for BI-1808
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
18 november, 2025
BioInvent has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) regarding orphan drug designation for BI-1808 in cutaneous T-cell lymphoma. According to CEO Martin Welschof, this step – together with the encouraging clinical data generated to date – reinforces the company’s commitment to advancing BI-1808 as a novel immunotherapy for CTCL patients.
Read the article at biostock.se:
BioInvent receives EMA support for BI-1808
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
Analys
Analys
1 DAG %
Senast
OMX Stockholm 30
−1,14%
(11:07)
Boliden
Idag, 10:03
Stockholmsbörsen rekylerar ned
Aktierekommendationer
Idag, 09:44
SEB säljstämplar Tele2
Asienbörserna
Idag, 08:07
Mestadels nedåt i Asien
oljepriset
Idag, 07:53
Oljepriserna lyfter på nytt
OMX Stockholm 30
1 DAG %
Senast
3 059,07